Finerenone, Placebo, Placebo, BAY 94-8862
21177
Phase 3 small_molecule active
Quick answer
Finerenone, Placebo, Placebo, BAY 94-8862 for Non-diabetic chronic kidney disease is a Phase 3 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Non-diabetic chronic kidney disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active